These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Twice-daily dosing of Nelfinavir approved. Res Initiat Treat Action; 1999 Dec 21; 5(5):22. PubMed ID: 11366888 [Abstract] [Full Text] [Related]
6. FDA approves nelfinavir. Food and Drug Administration. GMHC Treat Issues; 1997 Mar 21; 11(3):8. PubMed ID: 11364277 [Abstract] [Full Text] [Related]
7. Nelfinavir (Viracept) moves up the ranks. Grodeck B. Posit Aware; 1997 Mar 21; 8(2):16-7. PubMed ID: 11364452 [Abstract] [Full Text] [Related]
8. New dosing of ddI (Videx) and Nelfinavir (Viracept) approved. Highleyman L. BETA; 1999 Mar 21; 12(4):3. PubMed ID: 11367246 [Abstract] [Full Text] [Related]
9. Nelfinavir (Viracept). Res Initiat Treat Action; 2000 Mar 21; 6(1):30-1. PubMed ID: 11708185 [No Abstract] [Full Text] [Related]
17. FDA notifications. New dosing option approved for Viracept. AIDS Alert; 2003 Jul 05; 18(7):90. PubMed ID: 12846198 [No Abstract] [Full Text] [Related]
18. Opportunistic pricing: a new scourge, a new call for action. Proj Inf Perspect; 1998 Dec 05; (26):1-5. PubMed ID: 11366486 [Abstract] [Full Text] [Related]
19. Protease inhibitors at a glance... Notes Undergr; 1998 Dec 05; (No 38):suppl 1-4. PubMed ID: 11366198 [Abstract] [Full Text] [Related]